189 related articles for article (PubMed ID: 33252330)
21. Generating Bacterial Foods in Toxicology Studies with Caenorhabditis elegans.
Ke T; Santamaría A; Tinkov AA; Bornhorst J; Aschner M
Curr Protoc Toxicol; 2020 Jun; 84(1):e94. PubMed ID: 32436649
[TBL] [Abstract][Full Text] [Related]
22. Genomics of rapid adaptation to antibiotics: convergent evolution and scalable sequence amplification.
Laehnemann D; Peña-Miller R; Rosenstiel P; Beardmore R; Jansen G; Schulenburg H
Genome Biol Evol; 2014 May; 6(6):1287-301. PubMed ID: 24850796
[TBL] [Abstract][Full Text] [Related]
23. Fluorodeoxyuridine enhances the heat shock response and decreases polyglutamine aggregation in an HSF-1-dependent manner in Caenorhabditis elegans.
Brunquell J; Bowers P; Westerheide SD
Mech Ageing Dev; 2014; 141-142():1-4. PubMed ID: 25168631
[TBL] [Abstract][Full Text] [Related]
24. Potential for adaptation overrides cost of resistance.
Moura de Sousa J; Sousa A; Bourgard C; Gordo I
Future Microbiol; 2015; 10(9):1415-31. PubMed ID: 26343510
[TBL] [Abstract][Full Text] [Related]
25. Antibacterial activity of chemotherapeutic drugs against Escherichia coli and Staphylococcus pseudintermedius.
Campbell O; Gagnon J; Rubin JE
Lett Appl Microbiol; 2019 Nov; 69(5):353-357. PubMed ID: 31508840
[TBL] [Abstract][Full Text] [Related]
26. Lifespan extending activity of substances secreted by the nematode Caenorhabditis elegans that include the dauer-inducing pheromone.
Kawano T; Kataoka N; Abe S; Ohtani M; Honda Y; Honda S; Kimura Y
Biosci Biotechnol Biochem; 2005 Dec; 69(12):2479-81. PubMed ID: 16377915
[TBL] [Abstract][Full Text] [Related]
27. Global Proteomic Response of
Mir DA; Balamurugan K
Front Cell Infect Microbiol; 2019; 9():172. PubMed ID: 31214513
[TBL] [Abstract][Full Text] [Related]
28. Quantifying rapid bacterial evolution and transmission within the mouse intestine.
Vasquez KS; Willis L; Cira NJ; Ng KM; Pedro MF; Aranda-Díaz A; Rajendram M; Yu FB; Higginbottom SK; Neff N; Sherlock G; Xavier KB; Quake SR; Sonnenburg JL; Good BH; Huang KC
Cell Host Microbe; 2021 Sep; 29(9):1454-1468.e4. PubMed ID: 34473943
[TBL] [Abstract][Full Text] [Related]
29. An evolving role for oral fluoropyrimidine drugs.
Diasio RB
J Clin Oncol; 2002 Feb; 20(4):894-6. PubMed ID: 11844808
[No Abstract] [Full Text] [Related]
30. Strength of selection pressure is an important parameter contributing to the complexity of antibiotic resistance evolution.
Oz T; Guvenek A; Yildiz S; Karaboga E; Tamer YT; Mumcuyan N; Ozan VB; Senturk GH; Cokol M; Yeh P; Toprak E
Mol Biol Evol; 2014 Sep; 31(9):2387-401. PubMed ID: 24962091
[TBL] [Abstract][Full Text] [Related]
31. Host and gut bacteria share metabolic pathways for anti-cancer drug metabolism.
Spanogiannopoulos P; Kyaw TS; Guthrie BGH; Bradley PH; Lee JV; Melamed J; Malig YNA; Lam KN; Gempis D; Sandy M; Kidder W; Van Blarigan EL; Atreya CE; Venook A; Gerona RR; Goga A; Pollard KS; Turnbaugh PJ
Nat Microbiol; 2022 Oct; 7(10):1605-1620. PubMed ID: 36138165
[TBL] [Abstract][Full Text] [Related]
32. The Caenorhabditis elegans Proteome Response to Naturally Associated Microbiome Members of the Genus Ochrobactrum.
Cassidy L; Petersen C; Treitz C; Dierking K; Schulenburg H; Leippe M; Tholey A
Proteomics; 2018 Apr; 18(8):e1700426. PubMed ID: 29513928
[TBL] [Abstract][Full Text] [Related]
33. Modulation of Membrane Influx and Efflux in Escherichia coli Sequence Type 131 Has an Impact on Bacterial Motility, Biofilm Formation, and Virulence in a Caenorhabditis elegans Model.
Pantel A; Dunyach-Remy C; Ngba Essebe C; Mesureur J; Sotto A; Pagès JM; Nicolas-Chanoine MH; Lavigne JP
Antimicrob Agents Chemother; 2016 May; 60(5):2901-11. PubMed ID: 26926643
[TBL] [Abstract][Full Text] [Related]
34. Polymorphic tandem repeat sequences of the thymidylate synthase gene correlates with cellular-based sensitivity to fluoropyrimidine antitumor agents.
Yawata A; Kim SR; Miyajima A; Kubo T; Ishida S; Saito Y; Nakajima Y; Katori N; Matsumoto Y; Fukuoka M; Ohno Y; Ozawa S; Sawada J
Cancer Chemother Pharmacol; 2005 Nov; 56(5):465-72. PubMed ID: 15918040
[TBL] [Abstract][Full Text] [Related]
35. The population genetics of collateral resistance and sensitivity.
Ardell SM; Kryazhimskiy S
Elife; 2021 Dec; 10():. PubMed ID: 34889185
[TBL] [Abstract][Full Text] [Related]
36. Resistance Gene Carriage Predicts Growth of Natural and Clinical
Allen RC; Angst DC; Hall AR
Appl Environ Microbiol; 2019 Feb; 85(4):. PubMed ID: 30530714
[TBL] [Abstract][Full Text] [Related]
37. Bacteria and bacterial products: Foe and friends to Caenorhabditis elegans.
Khan F; Jain S; Oloketuyi SF
Microbiol Res; 2018 Oct; 215():102-113. PubMed ID: 30172296
[TBL] [Abstract][Full Text] [Related]
38. Paralysis and killing of Caenorhabditis elegans by enteropathogenic Escherichia coli requires the bacterial tryptophanase gene.
Anyanful A; Dolan-Livengood JM; Lewis T; Sheth S; Dezalia MN; Sherman MA; Kalman LV; Benian GM; Kalman D
Mol Microbiol; 2005 Aug; 57(4):988-1007. PubMed ID: 16091039
[TBL] [Abstract][Full Text] [Related]
39. Bacteria-derived metabolite, methylglyoxal, modulates the longevity of
Shin MG; Lee JW; Han JS; Lee B; Jeong JH; Park SH; Kim JH; Jang S; Park M; Kim SY; Kim S; Yang YR; Kim JY; Hoe KL; Park C; Lee KP; Kwon KS; Kwon ES
Proc Natl Acad Sci U S A; 2020 Jul; 117(29):17142-17150. PubMed ID: 32636256
[TBL] [Abstract][Full Text] [Related]
40. Folate Acts in E. coli to Accelerate C. elegans Aging Independently of Bacterial Biosynthesis.
Virk B; Jia J; Maynard CA; Raimundo A; Lefebvre J; Richards SA; Chetina N; Liang Y; Helliwell N; Cipinska M; Weinkove D
Cell Rep; 2016 Feb; 14(7):1611-1620. PubMed ID: 26876180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
